KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 139 filers reported holding KRYSTAL BIOTECH INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $715,372 | -0.7% | 6,167 | +0.5% | 0.00% | 0.0% |
| Q2 2023 | $720,484 | +23.2% | 6,137 | -16.0% | 0.00% | +100.0% |
| Q1 2023 | $584,998 | +1.1% | 7,307 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $578,861 | +7.4% | 7,307 | -5.4% | 0.00% | 0.0% |
| Q3 2022 | $539,000 | -6.6% | 7,727 | -12.1% | 0.00% | 0.0% |
| Q2 2022 | $577,000 | -1.2% | 8,787 | +0.1% | 0.00% | 0.0% |
| Q1 2022 | $584,000 | -4.9% | 8,777 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $614,000 | +34.1% | 8,777 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $458,000 | -23.3% | 8,777 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $597,000 | +101.0% | 8,777 | +127.4% | 0.00% | 0.0% |
| Q1 2021 | $297,000 | +31.4% | 3,860 | +2.7% | 0.00% | – |
| Q4 2020 | $226,000 | – | 3,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
| Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
| S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
| Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
| Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
| Artal Group S.A. | 412,082 | $32,991 | 1.96% |
| First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
| Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
| Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |